102 related articles for article (PubMed ID: 27480251)
1. Original Research: miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells.
Cui G; Liu D; Li W; Li Y; Liang Y; Shi W; Zhao S
Exp Biol Med (Maywood); 2017 Jan; 242(1):45-52. PubMed ID: 27480251
[TBL] [Abstract][Full Text] [Related]
2. Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis.
Huang J; Jin S; Guo R; Wu W; Yang C; Qin Y; Chen Q; He X; Qu J; Yang Z
RNA; 2024 Mar; 30(4):435-447. PubMed ID: 38296629
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B.
Li J; Hou F; Teng Z; Xia W; Peng J
J Cancer Res Clin Oncol; 2024 Jun; 150(6):294. PubMed ID: 38842683
[TBL] [Abstract][Full Text] [Related]
4. Increased Expression of Lysine-Specific Demethylase 5B (KDM5B) Promotes Tumor Cell Growth in Hep3B Cells and is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma.
Gong J; Yan S; Yu H; Zhang W; Zhang D
Med Sci Monit; 2018 Oct; 24():7586-7594. PubMed ID: 30353907
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA HOXA-AS2 Facilitates Prostate Cancer Progression by Inhibiting miR-885-5p to Upregulate KDM5B.
Yang Z; Zhang F; Cai K; Xu J
Kidney Blood Press Res; 2023; 48(1):45-55. PubMed ID: 36404720
[TBL] [Abstract][Full Text] [Related]
6. KDM5B promotes metastasis and epithelial-mesenchymal transition via Wnt/β-catenin pathway in squamous cell carcinoma of the head and neck.
Yuan W; Hu J; Wang M; Li G; Lu S; Qiu Y; Liu C; Liu Y
Mol Carcinog; 2024 May; 63(5):885-896. PubMed ID: 38353298
[TBL] [Abstract][Full Text] [Related]
7. MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9.
Lv Y; Ye D; Qiu S; Zhang J; Shen Z; Shen Y; Deng H
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519771
[TBL] [Abstract][Full Text] [Related]
8. JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma.
Macedo-Silva C; Miranda-Gonçalves V; Lameirinhas A; Lencart J; Pereira A; Lobo J; Guimarães R; Martins AT; Henrique R; Bravo I; Jerónimo C
Cell Death Dis; 2020 Dec; 11(12):1068. PubMed ID: 33318475
[TBL] [Abstract][Full Text] [Related]
9. miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma.
Zhang M; Zhou S; Zhang L; Zhang J; Cai H; Zhu J; Huang C; Wang J
FEBS Lett; 2012 Sep; 586(19):3508-21. PubMed ID: 22958893
[TBL] [Abstract][Full Text] [Related]
10. Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis.
Brown LK; Kanagasabai T; Li G; Celada SI; Rumph JT; Adunyah SE; Stewart LV; Chen Z
Prostate; 2024 Jun; 84(9):877-887. PubMed ID: 38605532
[TBL] [Abstract][Full Text] [Related]
11. miR-541 suppresses proliferation and invasion of squamous cell lung carcinoma cell lines via directly targeting high-mobility group AT-hook 2.
Xu L; Du B; Lu QJ; Fan XW; Tang K; Yang L; Liao WL
Cancer Med; 2018 Jun; 7(6):2581-2591. PubMed ID: 29659195
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer.
Yeh IJ; Esakov E; Lathia JD; Miyagi M; Reizes O; Montano MM
Sci Rep; 2019 Nov; 9(1):17663. PubMed ID: 31776402
[TBL] [Abstract][Full Text] [Related]
13. miR-1 suppresses the proliferation and promotes the apoptosis of esophageal carcinoma cells by targeting Src.
Liao Z; Wang X; Liang H; Yu A; Ur Rehman U; Fan Q; Hu Y; Wang C; Zhou Z; Wang T
Cancer Med; 2017 Dec; 6(12):2957-2965. PubMed ID: 29034995
[TBL] [Abstract][Full Text] [Related]
14. Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer.
Guan T; Zhang Y; Li S; Zhang W; Song Y; Li Y; He Y; Chen Y
Eur J Med Chem; 2024 Jun; 272():116494. PubMed ID: 38749268
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis.
Zhang B; Li J; Wang Y; Liu X; Yang X; Liao Z; Deng S; Deng Y; Zhou Z; Tian Y; Wei W; Meng J; Hu Y; Wan C; Zhang Z; Huang F; Wen L; Wu B; Sun Y; Li Y; Yang K
Cell Death Differ; 2024 Mar; 31(3):309-321. PubMed ID: 38287116
[TBL] [Abstract][Full Text] [Related]
16. MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation.
Li J; Wan X; Qiang W; Li T; Huang W; Huang S; Wu D; Li Y
Int J Clin Exp Med; 2015; 8(4):5329-39. PubMed ID: 26131109
[TBL] [Abstract][Full Text] [Related]
17. Lysine demethylase 5B (KDM5B): A key regulator of cancer drug resistance.
Cao Y; Wu C; Ma L
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23587. PubMed ID: 38014925
[TBL] [Abstract][Full Text] [Related]
18. MiR-499 Enhances the Cisplatin Sensitivity of Esophageal Carcinoma Cell Lines by Targeting DNA Polymerase β.
Wang Y; Feng J; Zang W; Du Y; Chen X; Sun Q; Dong Z; Zhao G
Cell Physiol Biochem; 2015; 36(4):1587-96. PubMed ID: 26159783
[TBL] [Abstract][Full Text] [Related]
19. Histone demethylase KDM5B licenses macrophage-mediated inflammatory responses by repressing Nfkbia transcription.
Zhang Y; Gao Y; Jiang Y; Ding Y; Chen H; Xiang Y; Zhan Z; Liu X
Cell Death Differ; 2023 May; 30(5):1279-1292. PubMed ID: 36914768
[TBL] [Abstract][Full Text] [Related]
20. Alcohol-associated fibrosis in females is mediated by female-specific activation of lysine demethylases KDM5B and KDM5C.
Schonfeld M; Averilla J; Gunewardena S; Weinman SA; Tikhanovich I
Hepatol Commun; 2022 Aug; 6(8):2042-2057. PubMed ID: 35468265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
